Publications in collaboration with researchers from Mayo Clinic (10)

2024

  1. Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)

    Journal of Clinical Medicine, Vol. 13, Núm. 9

2023

  1. Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2)

    Journal of Clinical Medicine, Vol. 12, Núm. 2

2021

  1. Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry

    American Heart Journal, Vol. 237, pp. 104-115

2013

  1. Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design

    Trials, Vol. 14, Núm. 1

2012

  1. Use and interpretation of composite end points in orthopaedic trials

    Journal of Bone and Joint Surgery, Vol. 94, Núm. SUPPL. 1, pp. 65-69

2010

  1. Stopping randomized trials early for benefit and estimation of treatment effects: Systematic review and meta-regression analysis

    JAMA, Vol. 303, Núm. 12, pp. 1180-1187

2009

  1. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: Systematic review and meta-regression analysis

    BMJ (Online), Vol. 338, Núm. 7693

  2. Composite outcomes can distort the nature and magnitude of treatment benefits in clinical trials

    Annals of Internal Medicine

  3. Stopping randomized trials early for benefit: A protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2)

    Trials, Vol. 10

2008

  1. Composite endpoints in clinical trials

    Revista Espanola de Cardiologia, Vol. 61, Núm. 3, pp. 283-290